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Abstract 
1. In the late 1960’s and early 1970’s, an outbreak of lymphoma and leukaemia in 
gibbons (Hylobatidae), attributed to the retrovirus gibbon ape leukaemia virus 
(GALV), was widely reported in the literature.  The virus was described as infecting 
11% of captive gibbons in the USA and as a worldwide threat, with cases in both 
south east Asia, which is the native habitat of gibbons, and in gibbon colonies across 
north America 
2. Since this time, GALV has been discussed as a danger to captive gibbons, a risk to 
humans handling primates and a potential confounding factor in primate based 
research  
3. The virus is a widespread cell culture contaminant and in particular research into HIV 
can be impeded by expression of GALV particles by HIV permissive cell lines . 
4. In this review, we bring together published work, laboratory records from early GALV 
research, correspondence about the transportation of gibbons during the 1960s and 
1970s, phylogenetic analyses, laboratory screening and zoological records for the 
first time to discover more about the origin and transmission of GALV.   
5. Based on this evidence, we propose that GALV was the result of a cross-species 
transmission event, most likely during a laboratory experiment, and was never 
widespread.  Instead, all infected gibbons were most likely either transported from 
the site of the original outbreak, were housed with gibbons from this site or were 
infected with material derived from gibbons from this site.   
6. We also propose that GALV is not an ongoing pathogen of contemporary wild or 
captive gibbons. 
  
Lymphoma and Leukaemia in Gibbons 
Lymphoma and leukaemia were not described in gibbons until the 1960’s, when several 
case reports of haematopoietic neoplasia in Hylobates gibbons in, or imported from, south 
east Asia were published (De Paoli and Garner, 1968; DiGiacomo, 1967; Lingeman et al., 
1969; Newberne and Robinson, 1960) .  In 1969, four further cases of malignant lymphoma 
were reported within a single colony of white-handed gibbons (Hylobates lar) and were 
attributed to an infectious agent, however the agent could not be identified (Johnsen et al., 
1969) (Table 1).  This agent was identified as an exogenous gammaretrovirus in 1971, when 
five further gibbons in this colony were diagnosed with granulocytic leukaemia  (De Paoli et 
al., 1971; Eiden and Taliaferro, 2011; Theilen et al., 1971) (Table 1).  The colony was 
located at the South East Asian Treaty Organisation (SEATO) laboratory, a US military 
research facility in Bangkok, Thailand.  Soon afterwards, in 1971, a type C 
(gammaretrovirus-like) retrovirus was identified in a woolly monkey (Lagothrix lagotricha) 
which was diagnosed with fibrosarcoma (Eiden and Taliaferro, 2011; Theilen et al., 1971) 
(Table 1). This monkey was kept as a pet in an apartment in San Francisco, alongside a lar 
gibbon (Hylobates lar) (Eiden and Taliaferro, 2011). Less than a year later, this gibbon was 
diagnosed with lymphosarcoma and another strain of the same retrovirus was identified as 
the cause (Kawakami et al., 1972) (Table 1). 
GALV (as this virus became known) was soon reported in several other locations. Kawakami 
et al. (1973) looked for antibodies to GALV in the sera of gibbons in various locations and 
found them to be widespread (Table 1).  The virus was then identified in frozen brain 
samples stored at the Gulf South Primate Center (GSPC) in New Iberia, Louisiana (Todaro 
et al., 1975) and  in a gibbon colony on Hall’s island in Bermuda (Gallo et al., 1978) (Table 
1).  It was during this period that GALV was described as infecting 11% of captive gibbons 
(Kawakami et al., 1973; Kawakami et al., 1975).  GALV has also appeared as a cell line 
contaminant on several occasions.  Gallagher and Gallo (1975), Okabe et al. (1976) and 
Chan et al. (1976) reported GALV in cells cultured from a single patient with acute 
  
myelogenous leukaemia (Table 1).  Later, in the 1990’s, this strain was identified in Belgium 
in HUT78 cells infected with HIV-1 strain ARV-2 (Burtonboy et al., 1993; Parent et al., 1998) 
(Table 1).  Expression of GALV by HIV permissive cell lines has also been observed more 
recently (Takeuchi et al., 2008). 
There are five known strains of GALV: GALV San Francisco (GALV-SF),  identified in the pet 
gibbon in San Francisco described above and later in gibbon colonies in San Francisco and 
at the University of California at Davis (UC Davis) Comparative Oncology Laboratory (COL); 
GALV-SEATO, found only in gibbons originating from the SEATO gibbon colony; GALV-X, 
found in cell culture in Louvain, Belgium and at the National Cancer Institute (NCI)  in 
Maryland, USA; GALV-H, only identified in gibbons at the Hall’s Island colony in Bermuda 
and GALV-Brain, identified in frozen brain samples at the GSPC in Louisiana (Figure 1).  
 
Phylogenetic History 
Phylogenetically, GALV falls within a cluster of retroviruses which are otherwise largely 
found in rodents (Figure 1).  No other exogenous or endogenous retroviruses from primates 
fall within this cluster (Figure 1).  Until recently, koala retrovirus (KoRV) was the most similar 
known retrovirus to GALV.  KoRV is an active pathogen in koalas,  most likely having 
entered their population within the last several hundred years (Tarlinton et al., 2006).  As 
gibbons and koalas are distant both evolutionarily and geographically, it is generally 
considered that the virus originated separately in both groups via another host, most likely 
an Asian rodent or a bat (Eiden and Taliaferro, 2011; Simmons et al., 2014).  Early reports 
suggested that GALV was closely related to relatives of MLV in south east Asian rodents, 
most notably Mus dunni endogenous virus (MdEV) in the Earth-coloured mouse (now known 
as Mus terricolor) and Mus caroli endogenous virus (McEV) in the Ryukuyu mouse (Callahan 
et al., 1979; Lieber et al., 1975).  However, these results were derived from low resolution 
serological and DNA homology methods, including cross-reacting but poorly defined 
  
epitopes of the capsid subunit.  Sequence information from these viruses is now available 
and phylogenetic analysis shows that they cluster separately to GALV and KoRV (Figure 1) 
with sequence identity to GALV-SEATO of only 68-69% for pol and 55% for env.  As KoRV 
is found only in Australian marsupials and GALV only in south east Asian primates, 
Simmons et al. (2014) screened species of bats and rodents which are found in both 
Australia and southeast Asia for GALV-like ERVs.   Pol and env gene fragments were 
identified clustering closely between GALV and KoRV in the Grassland mosaic-tailed rat 
(Melomys burtoni) (Simmons et al., 2014) (Figure 1).   There is no clear ecological overlap 
between gibbons and M. burtoni, as M. burtoni is restricted to north eastern Australia and 
Papua New Guinea and no Melomys species occur  in any part of mainland south east Asia, 
while gibbons are limited to mainland south east Asia (Nowak, 1999).  No primate 
retroviruses are known with a close genetic relationship to GALV. 
 
GALV in Contemporary Primates 
No scientific publications have reported GALV in a live gibbon for almost 40 years, but it is 
still considered by many to be an active pathogen.   A recent study screened gibbons held in 
north American zoological institutes for GALV and reported no animals with PCR or culture 
detectable virus (Siegal-Willott et al., 2015).  This study reported serum antibodies cross-
reacting with cell culture GALV isolates in a bespoke ELISA in 28% of the 76 animals tested, 
however without data on the potential cross-reactivity of this serum with other retroviruses 
(including the fragments of other gammaretroviruses within the gibbon genome) it is difficult 
to interpret the specificity of this seroreactivity.   
We have used a combination of zoological records and PCR screening to search for 
contemporary cases of GALV. Zoological records of 48 gibbons and 20 woolly monkeys 
dating from 1964 to 2008 were obtained from records held at a UK zoo. None of these 
primates was described as infected with GALV and only one had clinical signs consistent 
  
with GALV at post-mortem, listed as “mediastinal and intestinal lymphadenopathy, lymphatic 
enlargement of spleen, liver and kidney and gastric ulceration”. This gibbon died in 2006, 
long after the major GALV outbreak was described, and was not tested for GALV.  Samples 
from gibbons sourced from throughout the EU, of diverse origins, were obtained  from the 
Deutsches Primatenzentrum, Goettingen, Germany.  DNA was extracted from 23 blood 
samples from seven species of gibbon.  Despite being subjected to multiple PCR screens, 
none of the contemporary gibbon samples tested positive for GALV or KoRV in any analysis 
(details of samples and PCR screening are available as Supplementary Methods). A control 
PCR using β-actin primers confirmed that all samples were all of sufficient quality for PCR 
amplification.  These primers and conditions have previously been used successfully to 
amplify GALV and KoRV.  Therefore, consistent with the findings of Siegal-Willott et al. 
(2015), it appears that GALV and KoRV are absent in these gibbons.  
 
Endogenous Elements Related to GALV 
We also performed a similarity based in silico screen for endogenous retrovirus (ERV) 
elements related to KoRV, GALV and M. burtoni ERV in the gibbon genome, plus all 
available rodent and primate reference genomes (listed in Supplementary Methods), using 
previously published methodology (Brown et al., 2014).  Briefly, using the Exonerate 
algorithm (Slater and Birney, 2005), regions of reference genomes with high similarity to 
known retroviruses were identified.  For each of these regions, the Smith-Waterman 
algorithm (Smith and Waterman, 1981) was used, via the EMBOSS water function (Rice et 
al., 2000) to generate a similarity score with the pol gene of the GALV reference sequence 
(Genbank accession NC_001885.2).  The highest scoring sequence from each host was 
considered to be the closest endogenous relative to GALV in that host. 
The most similar endogenous relatives of GALV were identified in the mouse (Mus 
musculus), rat (Rattus norvegicus) and hamster (Cricetulus griseus) genomes.  These 
  
sequences cluster together phylogenetically and are similar to Mus caroli endogenous virus 
and Mus dunni endogenous virus and somewhat distant from GALV (Figure 1).  The most 
similar endogenous element identified in the gibbon genome was considerably more distant 
from GALV, clustering with the human endogenous retrovirus HERV-T (Figure 1).  This 
shows that there is unlikely to be a longstanding evolutionary relationship between GALV 
and their gibbon hosts. 
 
Linking Historical Cases of GALV 
The absence of confirmed GALV in contemporary gibbons is surprising, given the worldwide 
distribution, rapid diversification and high prevalence of GALV reported during the initial 
outbreak.  The absence of GALV in gibbons in the UK during the GALV outbreak period  
suggests that the documented prevalence of 11% in the USA. which is still cited today (e.g. 
Voevodin and Marx (2009) , originally from Kawakami et al. (1973) and Kawakami et al. 
(1975), was never the case worldwide. Therefore, besides these early publications, we 
obtained the 1963 to 1983 SEATO Medical Research Laboratory Annual Progress reports 
(http://www.afrims.org/weblib/apr/aprF.shtml), archived documentation from the US 
Department of State concerning gibbon transportation (documents 1974BANGKO17800, 
1974STATE260768_b, 1974BANGKO17734_b,1974STATE260770_b, 
1974TAIPEI06749_b, 1974STATE244644_b, 1974BANGKO19028_b, 
1975BANGKO15111_b, available at www.wikileaks.org) and scanned documents from this 
period maintained by the International Primate Protection League (IPPL) (available at 
https://www.ippl.org).  
The two studies which provide the statistic of 11% GALV prevalence were based on 133 
gibbons from five US colonies, of which 15 had antibodies reactive to a GALV antigen. 
However, breaking down this statistic, the 15 gibbons with these antibodies were all from 
one of three research colonies, those at the UC Davis COL, SEATO and the SFMC.   None 
  
of the remaining 31 gibbons, from colonies elsewhere in the USA, had these antibodies.  
Therefore, rather than a worldwide prevalence of 11%, this study, which is the largest known 
study of GALV, documents 15 potential cases of GALV.  These cases were all within 
colonies located at research facilities known to have worked on GALV prior to this 
publication (after GALV was first described at SEATO, it was detected at UC Davis COL in a 
gibbon obtained from the SFMC) (Table 1).  This raises the possibility of a link between 
these cases.  SEATO gibbons appear to have been exported to primate laboratories at UC 
Davis on at least one occasion during the 1960s and 1970s (Table 2).  Gibbons from 
unknown locations in Thailand are also known to have been exported to UC Davis via animal 
dealers on a number of occasions during this period (Table 2).  Therefore, an outbreak of 
GALV at the UC Davis and SFMC colonies coinciding with the outbreak at SEATO may be 
the result of shipment of an infected gibbon, either from within SEATO or from a more 
widespread outbreak in Thailand.  The isolated GALV-SF and WMSV cases identified in a 
gibbon and woolly monkey kept together as pets in a San Francisco apartment building 
(Eiden and Taliaferro, 2011) can be similarly explained by the numerous legal and illegal 
shipments of gibbons from south east Asia during this period.  The SEATO colony included a 
group of free-ranging gibbons (Berkson, 1968), so direct capture from this colony is even a 
possibility, as primate dealing was lucrative and poorly regulated in Thailand at this time. 
GALV-H, from gibbons in Bermuda, and GALV-Brain, from frozen tissue at the GPC, are 
similar to GALV-SEATO, with which they form a slightly distinct phylogenetic group to GALV-
SF and GALV-X (Figure 1).  This suggests a close relationship between GALV-SEATO, 
GALV-H and GALV-Br.  This would be consistent with a direct link between the gibbons in 
these locations, which is not initially apparent from the publications describing these strains.  
However, during the 1970’s the IPPL, an organisation campaigning for primate welfare, kept 
and published records of movement of gibbons around the world, and information published 
by this organisation provides us with a possible link.  In their March 1976 and February 1977 
newsletters (before the first publication relating to GALV-H in 1979), the IPPL reported on 
  
the origin of the gibbons at the newly established Hall’s Island colony (Table 1, Table 2).  
The gibbons were reported to have originated in Thailand and 10 of the gibbons as from the 
“US army gibbon laboratory”, likely to be the SEATO colony, in Bangkok (Table 1, Table 2).   
This would be consistent with our phylogenetic and other analyses.  The GALV-Br strain in 
Louisiana is harder to trace, but reviewing the literature leads to two potential routes.  The 
Delta Primate Center (now the Tulane National Primate Research Center) in Covington, 
Louisiana, is reported by the IPPL in their April 1978 newsletter to have received 20 gibbons 
from SEATO in 1963 (Table 2).  The Gulf South Primate Center, in New Iberia, Louisiana, is 
situated approximately 130 miles away and it is feasible that gibbons were moved between 
these locations during the 1960’s.  The gibbon brain samples in which GALV was identified 
were from gibbons exported from southeast Asia in 1968.  They may therefore have been in 
contact with SEATO or other gibbons in south east Asia prior to this shipment or interacted 
with gibbons from SEATO while in the US.  These gibbons were inoculated with kuru 
affected human brain tissue from Papua New Guinea (Todaro et al., 1975), so laboratory 
exposure is also possible.  Alternatively, as the brains from which GALV-Br was isolated 
were from seemingly healthy gibbons, the cell lines with which the gibbon brain tissue was 
co-cultured may have been contaminated with GALV-Br.   
Cell lines contaminated with GALV-X can also be traced back to laboratories where 
significant amounts of work on GALV have been carried out (Table 1). For example, 
Gallagher and Gallo (1975) identified GALV-X at the NIH National Cancer Institute in 
Maryland, USA, where Lieber et al. (1975) and Todaro et al. (1975) cultured strains of GALV 
(Table 1).  Burtonboy et al. (1993) and Parent et al. (1998) worked at the University of 
Louvain, Belgium but the HIV-1 infected cell line from which they isolated GALV was 
established at the University of California, and some reagents used in this process were 
obtained from GALV researchers at the NIH National Cancer Institute (Levy et al., 1984). 
The GALV-X  strain is highly similar to GALV-SF (Figure 1) and may represent GALV-SF 
simply preserved in a cell line and shipped to another laboratory. 
  
Archived documents from the SEATO medical research laboratory provide further 
information about the SEATO gibbons.  The colony was established in 1966 with 71 gibbons 
(most likely Hylobates lar) purchased in Thailand (Morris et al., 1966). SEATO gibbons were 
used as models for human disease pathogenesis and transmission (primarily of malaria and 
dengue fever) and were inoculated frequently with blood and tissue from humans, rodents 
and other gibbons [e.g. (Bancroft et al., 1975; Cadigan et al., 1967; Smith et al., 1968) ].  
The earliest identification of GALV was in four gibbons in this colony which had all been part 
of the malaria or dengue virus studies at the centre. Both of these studies were long-term, 
involved many gibbons and used transfusion of blood between gibbons and from humans to 
gibbons, viruses grown in live rodents and rodent tissues and transmission experiments 
using mosquitoes fed on infected blood from rodents and gibbons (Diggs and Pavanand, 
1969; Halstead, 1964; Johnsen et al., 1969; Muangman, 1971). A large collection of Asian 
rodents was held at this facility and also used in these disease studies (Marshall, 1974, 
1975).  This colony provides an attractive candidate for the location of the overspill event 
from rodents to gibbons, either through laboratory inoculation with material from humans or 
other species or via direct contact between animals. At least two of the gibbons with 
confirmed GALV at this colony (identified as gibbons S-76 and S-77) were involved in the 
same malaria study (Cadigan et al., 1967; De Paoli et al., 1971). The identification numbers 
of gibbons involved in studies were only sporadically reported, so the exact transmission 
path of the disease cannot be tracked. 
As several previous studies have proposed [e.g. (Eiden and Taliaferro, 2011; Hayward et al., 
2013; Lieber et al., 1975; Tarlinton et al., 2008)] , we hypothesise that GALV in gibbons 
originated as a cross-species transmission from rodents. The presence of a GALV/KoRV like 
ERV in an Australian rodent (Simmons et al., 2014) adds strength to this hypothesis.  GALV 
strains are extremely similar to each other genetically and the divergence of the env gene 
between strains of GALV, which ranges from 85% to 99%, is no greater than the divergence 
of env genes in the viral population within a single HIV-1 infected individual, so they may 
  
represent different isolates from a single outbreak (Andréoletti et al., 2007).   Laboratory 
analysis suggests that GALV is absent in contemporary European and North American  
Gibbons (Siegal-Willott et al., 2015) and analysis of veterinary records suggests it was 
absent in the UK when the virus was circulating elsewhere.  We propose that the spillover 
event from rodents to gibbons occurred either at the SEATO research colony or elsewhere in 
southeast Asia during the mid to late 1960’s. Gibbons from this region were exported to 
COL, SFMC and Hall’s Island, where GALV was again detected. GALV became a common 
cell culture contaminant in the laboratories where this work was carried out, so was later 
detected in cell lines linked to these laboratories. The lack of documented cases of GALV 
worldwide since 1978, along with these results, suggest that this virus is no longer an active 
pathogen of gibbons and that it was never widespread amongst the gibbon population. 
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Table 1: Key publications concerning the initial outbreak of GALV and the virus host, the 
geographical origin of the primates or cells in which the virus was identified, the location at 
which the virus was identified, the location of the laboratory work performed and the strain of 
GALV described. 
Publication Host Origin of primates or 
cells 
Location of 
material 
when 
tested 
Location of 
laboratory 
work 
Strain 
Johnsen et al., 
1969 
4 gibbons Purchased in Thailand 
(Morris et al., 1966) then 
SEATO Medical Research 
Colony 
SEATO 
Medical 
Research 
Colony. 
Unknown GALV-
SEATO 
De Paoli et al., 
1971 
 
5 gibbons Purchased in Thailand 
(Morris et al., 1966) then 
SEATO Medical Research 
Colony 
SEATO 
Medical 
Research 
Colony. 
UC Davis 
Comparative 
Oncology 
Laboratory 
GALV-
SEATO 
Theilen et al., 
1971 
1 woolly monkey Unknown, kept as a pet in 
an apartment in San 
Francisco 
UC Davis 
Veterinary 
Center. 
UC Davis 
Dept of 
Veterinary 
Medicine 
WMSV 
Kawakami et al., 
1972 
1 gibbon Unknown,  kept as a pet in 
an apartment in San 
Francisco with the woolly 
monkey described by 
Theilen et al. (1971) 
San 
Francisco 
Medical 
Center, 
University of 
California. 
UC Davis 
Comparative 
Oncology 
Laboratory 
GALV-SF 
Kawakami et al., 
1973 
15 gibbons Various UC Davis 
Comparative 
Oncology 
Laboratory 
(sera only) 
UC Davis 
Comparative 
Oncology 
Laboratory 
GALV-
SEATO 
GALV-SF 
Todaro et al., 
1975 
5 gibbons Imported from south East 
Asia to the Gulf South 
Primate Center, Louisiana 
in 1968, inoculated with 
brain tissue from humans  
from Papua New Guinea 
with kuru.  
Gulf South 
Primate 
Center, 
Louisiana. 
National 
Cancer 
Institute, 
Maryland. 
GALV-Br 
Gallagher and 
Gallo, 1975 
Okabe et al., 
1976 
Chan et al., 1976 
Cultured cells 
from a human 
with  acute 
myeloid 
leukaemia. 
Patient from Houston, 
Texas. 
Laboratory 
of Tumor 
Cell Biology, 
National 
Cancer 
Insititute, 
Maryland 
National 
Cancer 
Institute, 
Maryland 
GALV-X 
Gallo et al., 
1978 
1 gibbon “US army gibbon 
laboratory” and elsewhere 
in Thailand then Hall’s 
Island, Bermuda 
Rockland 
Research 
Institute, 
New York. 
National 
Cancer 
Insititute, 
Maryland 
GALV-H 
Burtonboy et al., 
1993 
HUT78 cells 
infected with HIV-
1 
Cancer Research 
Institute, San Francisco, 
then Vrije Universiteit, 
Brussels 
University of 
Louvain, 
Brussels. 
University of 
Louvain, 
Brussels. 
GALV-X 
 
  
Table 2: Details of documented international shipments of gibbons during the 1960s and 
1970s. 
 
Shipment Date Evidence  
SEATO, Bangkok to Delta 
Primate Center, Louisiana 
May 
1963 
IPPL newsletter, April 1978 
based on information supplied 
by the M.D. Director of 
SEATO. 
http://www.ippl.org/newsletter/1970s/014_v05_n1
_1978-04.pdf 
“US Army Gibbon 
Laboratory”, Bangkok, Dusit 
Zoo Bangkok and unknown 
other locations in Thailand 
to Hall’s Island, Bermuda 
1970-
1972 
IPPL newsletter, Feb 1977 
and IPPL newsletter, Mar 
1976 
https://www.ippl.org/newsletter/1970s/011_v04_n
1_1977-02.pdf 
https://www.ippl.org/newsletter/1970s/008_v03_n
1_1976-03.pdf 
Unknown locations in 
Thailand to UC Davis 
Comparative Oncology 
Laboratory, California 
1972-
1974 
US Fish and Wildlife Service  https://www.wikileaks.org/plusd/cables/1974STAT
E260768_b.html 
SEATO, Bangkok to UC 
Davis Comparative 
Oncology Laboratory, 
California 
Aug 
1973 
IPPL newsletter, April 1978 
based on information supplied 
by the M.D. Director of 
SEATO. 
http://www.ippl.org/newsletter/1970s/014_v05_n1
_1978-04.pdf 
 
 
Figure Legends 
Figure 1 
The phylogenetic relationship of the pol gene of strains of gibbon ape leukaemia virus, koala 
retrovirus, Melomys burtoni retrovirus and related retroviruses.  Orange dots mark rodent 
sequences, blue crosses primate sequences and green lines marsupial sequences.  GALV 
and WMSV are labelled and shown in blue.  Newly identified sequences identified in our in 
silico screen are shown in capital letters and in pink.  Sequence identifiers are shown in 
grey, these are Genbank accession numbers where available, otherwise Repbase identifier 
or chromosome with start and end positions are provided.  Chromosome positions are for 
the following genome builds: mouse GRCm38.p1, rat Rnor_5.0, gibbon Nleu_3.0.  
Sequences were aligned using the MAFFT L-INS-I algorithm (Katoh et al., 2002) with 1000 
iterations and the tree was generated using PhyML NNI (Guindon et al., 2010) with 
optimised tree topology, no invariable sites, optimised across site rate variation and a BioNJ 
starting tree.  Branch support is aLRT-like.   
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